CytomX Therapeutics, Inc. (CTMX) Capital expenditures 2016–2025
CytomX Therapeutics, Inc. (CTMX) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$220,000FY2025 · since FY2016: $2.2M → $220,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $220,000 | -29.0% |
| FY2024 | $310,000 | -63.1% |
| FY2023 | $840,000 | -51.7% |
| FY2022 | $1.7M | +8.1% |
| FY2021 | $1.6M | -30.3% |
| FY2020 | $2.3M | -34.0% |
| FY2019 | $3.5M | -7.7% |
| FY2018 | $3.8M | +143.0% |
| FY2017 | $1.6M | -28.4% |
| FY2016 | $2.2M | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice